|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 5,750 KRW | +0.17% |
|
0.00% | -5.74% |
ImmPACT Bio USA Inc. announced that it will issue 7,102,820 series B preferred shares at issue price of $15.6073 per share for the gross proceeds $110,855,842.586 in funding on January 14, 2022. The shares are convertible and cumulative. The shares carry cumulative fixed dividend rate of 8% per annum.
The shares will be convertible in common shares at a fixed conversion price of $15.6073 per share. The company will issue securities pursuant to exemption provided under Regulation D.
| 1st Jan change | Capi. | |
|---|---|---|
| -5.74% | 287M | |
| +17.00% | 42.79B | |
| +22.20% | 22.81B | |
| +15.52% | 15.04B | |
| +18.45% | 14.49B | |
| +51.24% | 12.65B | |
| -11.45% | 6.74B | |
| -0.05% | 6.79B | |
| -8.87% | 5.73B | |
| +14.55% | 5.47B |
BUKWANG PHARMACEUTICAL CO., LTD. 
